Sedana Medical AB (publ) (STO:SEDANA)

Market Cap	1.04B
Revenue (ttm)	187.43M
Net Income (ttm)	-54.77M
Shares Out	99.34M
EPS (ttm)	-0.56
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	236,850
Average Volume	380,579
Open	10.82
Previous Close	10.84
Day's Range	10.50 - 10.82
52-Week Range	6.65 - 28.60
Beta	0.91
RSI	36.69
Earnings Date	Jul 18, 2025

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care; and AnaConDa, a medical device enabling the adminis...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 109
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SEDANA

Financial Performance

In 2024, Sedana Medical AB's revenue was 178.75 million, an increase of 16.17% compared to the previous year's 153.87 million. Losses were -10.67 million, -82.09% less than in 2023.